Cited by 2,310Statistical Methods in Clinical TrialsProbability and Statistical ResearchStatistical Methods and Bayesian Inference

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Discrete sequential boundaries for clinical trials

GORDON LAN, K. K., DEMETS, DAVID L.·1983·Biometrika

DOI 10.1093/biomet/70.3.659

Open this paper in CoChat — free account

Abstract

Pocock (1977), O'Brien & Fleming (1979) and Slud & Wei (1982) have proposed different methods to construct discrete sequential boundaries for clinical trials. These methods require that the total number of decision times be specified in advance. In the present paper, we propose a more flexible way to construct discrete sequential boundaries. The method is based on the choice of a function, α*(t), which characterizes the rate at which the error level α is spent. The boundary at a decision time is determined by α*(t), and by past and current decision times, but does not depend on the future decision times or the total number of decision times.

Integrity signals

Registry

Crossref · 10.1093/biomet/70.3.659

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society Series A (General) · doi:10.2307/2343787 · Cited by 772
Stochastically curtailed tests in long–term clinical trials
Lan, K. K. G., Simon, R. M., & Halperin, M. (1982) · Sequential Analysis · doi:10.1080/07474948208836014 · Cited by 356
Interim Analyses for Randomized Clinical Trials: The Group Sequential Approach
Pocock, S. (1982) · Biometrics · doi:10.2307/2530298 · Cited by 265
Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic
SLUD, E. V., & Wei, L. (1982) · Journal of the American Statistical Association · doi:10.1080/01621459.1982.10477899 · Cited by 244
Crossing probabilities for a square root boundary by a bessel process
Long, D. M. D. (1981) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928108828182 · Cited by 135
Sequential Testing of the Equality of Two Survival Distributions Using the Modified Savage Statistic
Koziol, J. A., & Petkau, A. J. (1978) · Biometrika · doi:10.1093/biomet/65.3.615 · Cited by 38
A two sample wilcoxon test for progressively censored data
DAVIS, C. E. (1978) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927808827630 · Cited by 23
Rank order tests for grouped data under progressive censoring
Majumdar, H., & Sen, P. K. (1977) · Communication in Statistics- Theory and Methods · doi:10.1080/03610927708827511 · Cited by 9

Show all 10 references

Sorted by citations

Items 701–800 of 1,001

Statistical Challenges in the Evaluation of Treatments for Small Patient Populations
Korn, E. L., McShane, L. M., & Freidlin, B. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004018 · Cited by 55
Citicoline for treating people with acute ischemic stroke
Martí-Carvajal, A. J., Valli, C., Martí-Amarista, C. E., Solà, I., Martí‐Fábregas, J., & Bonfill, X. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013066.pub2 · Cited by 58
Restricted mean survival time as a summary measure of time‐to‐event outcome
Hasegawa, T., Misawa, S., Nakagawa, S., Tanaka, S., Tanase, T., Ugai, H., Wakana, A., Yodo, Y., Tsuchiya, S., Suganami, H., et al. (2020) · Pharmaceutical Statistics · doi:10.1002/pst.2004 · Cited by 54
Statistical Challenges in Online Controlled Experiments: A Review of A/B Testing Methodology
Larsen, N., Stallrich, J. W., Sengupta, S., Deng, A., Kohavi, R., & Stevens, N. T. (2023) · The American Statistician · doi:10.1080/00031305.2023.2257237 · Cited by 73
Design of Phase II cancer trials evaluating survival probabilities
Case, L. D., & Morgan, T. M. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-6 · Cited by 54
Estimating and reducing bias in group sequential designs with Gaussian independent increment structure
Pinheiro, J. C. (1997) · Biometrika · doi:10.1093/biomet/84.4.831 · Cited by 54
Adaptive Dose-Response Studies
Gaydos, B. L., Krams, M., Perevozskaya, I. T., Bretz, F., Liu, Q., Gallo, P. P., Berry, D. A., Chuang‐Stein, C., Pinheiro, J., & Bedding, A. W. (2006) · Drug Information Journal · doi:10.1177/216847900604000411 · Cited by 54
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?
Kunz, C. U., Jörgens, S., Bretz, F., Stallard, N., Lancker, K. V., Xi, D., Zohar, S., Gerlinger, C., & Friede, T. (2020) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2020.1799857 · Cited by 54
A TRIAL OF THE BETA-BLOCKER BUCINDOLOL IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE
Nvestigators, T. R. I. (2001) · Cited by 54
Repeated Confidence Intervals for the Median Survival Time
Jennison, C., & Turnbull, B. W. (1985) · Biometrika · doi:10.1093/biomet/72.3.619 · Cited by 54
Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480
Small, E. J., Halabi, S., Ratain, M. J., Rosner, G. L., Stadler, W. M., Palchak, D., Marshall, M. E., Rago, R. P., Hárs, V., Wilding, G., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.022 · Cited by 54
Use of Logrank Tests and Group Sequential Methods at Fixed Calendar Times
DeMets, D. L., & Gail, M. H. (1985) · Biometrics · doi:10.2307/2530975 · Cited by 54
Self-citation
Interim Analyses with Repeated Measurements in a Sequential Clinical Trial
Wei, L., Su, J. Q., & Lachin, J. M. (1990) · Biometrika · doi:10.1093/biomet/77.2.359 · Cited by 54
Antithrombin III for critically ill patients
Afshari, A., Wetterslev, J., Brok, J. S., & Møller, A. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005370.pub2 · Cited by 54
Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial
the SUP-ICU investigators, Krag, M., Perner, A., Wetterslev, J., Wise, M. P., Borthwick, M., Bendel, S., Pelosi, P. P., Keus, F., Guttormsen, A. B., et al. (2016) · Trials · doi:10.1186/s13063-016-1331-3 · Cited by 53
Design and Monitoring of Multi-Arm Multi-Stage Clinical Trials
Ghosh, P., Liu, L., Senchaudhuri, P., Gao, P., & Mehta, C. R. (2017) · Biometrics · doi:10.1111/biom.12687 · Cited by 53
Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
Jeon, K., Song, J., Chung, C. R., Yang, J. H., & Suh, G. Y. (2018) · Critical Care · doi:10.1186/s13054-018-2034-9 · Cited by 56
Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix
Hoffman, M., Clifton, R. G., Biggio, J., Saade, G. R., Ugwu, L. G., Longo, M., Bousleiman, S., Clark, K., Grobman, W. A., Frey, H. A., et al. (2023) · JAMA · doi:10.1001/jama.2023.10812 · Cited by 58
Interim analyses and sequential designs in phase III studies
Todd, S., Whitehead, A., Stallard, N., & Whitehead, J. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01382.x · Cited by 53
A Randomized Trial of the Effects of Nebulized Albuterol on Pulmonary Edema in Brain-Dead Organ Donors
Ware, L. B., Landeck, M., Koyama, T., Zhao, Z., Singer, J. P., Kern, R. M., Neidlinger, N. A., Nguyen, J., Johnson, E., Janz, D. R., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12564 · Cited by 53
Alternative Views On Setting Clinical Trial Futility Criteria
Gallo, P. P., Mao, L., & Shih, V. H. (2014) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2014.932285 · Cited by 53
A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial)
Kimura, T., Nagata, Y., Eba, J., Ozawa, S., Ishikura, S., Shibata, T., Ito, Y., Hiraoka, M., & Nishimura, Y. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyw198 · Cited by 53
Comparing alternating pressure mattresses and high-specification foam mattresses to prevent pressure ulcers in high-risk patients: the PRESSURE 2 RCT
Nixon, J., Brown, S. T., Smith, I. L., McGinnis, E., Vargas‐Palacios, A., Nelson, E. A., Brown, J. M., Coleman, S. B., Collier, H., Fernandez, C., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23520 · Cited by 53
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)
Nakajima, T. E., Yamaguchi, K., Boku, N., Hyodo, I., Mizusawa, J., Hara, H., Nishina, T., Sakamoto, T., Shitara, K., Shinozaki, K., et al. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01043-x · Cited by 53
A 25‐year review of sequential methodology in clinical studies
Todd, S. (2006) · Statistics in Medicine · doi:10.1002/sim.2763 · Cited by 53
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
Shi, Y., Han, G., Zhou, J., Shi, X., Jia, W., Cheng, Y., Jin, Y., Hua, X., Wen, T., Wu, J., et al. (2025) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(25)00059-7 · Cited by 59
Sequential Implementation of Monte Carlo Tests With Uniformly Bounded Resampling Risk
Gandy, A. (2009) · Journal of the American Statistical Association · doi:10.1198/jasa.2009.tm08368 · Cited by 52
Sequential Equivalence Testing and Repeated Confidence Intervals, with Applications to Normal and Binary Responses
Jennison, C., & Turnbull, B. W. (1993) · Biometrics · doi:10.2307/2532600 · Cited by 52
A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted Diseases
Roddy, R. E., Zekeng, L. A., Ryan, K. A., Tamoufe, U., Weir, S. S., & Wong, E. L. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61754-3 · Cited by 52
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Armstrong, P. W., Adams, P. X., Al‐Khalidi, H. R., Hamm, C. W., Holmes, D. R., O’Neill, W. W., Todaro, T. G., Vahanian, A. S., de Werf, F. V., & Granger, C. B. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.015 · Cited by 52
Myocardial Infarction - Stress PRevention INTervention (MI-SPRINT) to reduce the incidence of posttraumatic stress after acute myocardial infarction through trauma-focused psychological counseling: study protocol for a randomized controlled trial
Meister, R. E., Princip, M., Schmid, J., Schnyder, U., Barth, J., Znoj, H., Herbert, C., & von Känel, R. (2013) · Trials · doi:10.1186/1745-6215-14-329 · Cited by 52
Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)
Mizusawa, J., Morizane, C., Okusaka, T., Katayama, H. G., Ishii, H., Fukuda, H., & Furuse, J. (2016) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv213 · Cited by 51
Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial
Viscoli, C. M., Brass, L. M., Carolei, A., Conwit, R., Ford, G. A., Furie, K. L., Gorman, M., Guarino, P. D., Inzucchi, S. E., Lovejoy, A. M., et al. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.07.016 · Cited by 50
Flexible sequential designs for multi‐arm clinical trials
Magirr, D., Stallard, N., & Jaki, T. (2014) · Statistics in Medicine · doi:10.1002/sim.6183 · Cited by 50
CBER’s Experience With Adaptive Design Clinical Trials
Lin, M. J., Lee, S., Zhen, B., Scott, J., Horne, A. D., Solomon, G., & Russek‐Cohen, E. (2015) · Therapeutic Innovation & Regulatory Science · doi:10.1177/2168479015604181 · Cited by 51
Central venous catheter (CVC) removal for patients of all ages with candidaemia
Janum, S., & Afshari, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011195.pub2 · Cited by 50
Futility approaches to interim monitoring by data monitoring committees
DeMets, D. L. (2006) · Clinical Trials · doi:10.1177/1740774506073115 · Cited by 50
Self-citation
Interim analysis of continuous long‐term endpoints in clinical trials with longitudinal outcomes
Galbraith, S., & Marschner, I. C. (2003) · Statistics in Medicine · doi:10.1002/sim.1311 · Cited by 50
SEQUENTIAL MONITORING OF RESPONSE-ADAPTIVE RANDOMIZED CLINICAL TRIALSPreprint
Zhu, H., & Hu, F. (2016) · Cited by 49
Sequential Implementation of Monte Carlo Tests with Uniformly Bounded Resampling RiskPreprint
Gandy, A. (2008) · Cited by 49
Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini‐Sentinel pilot
Cook, A. J., Tiwari, R. C., Wellman, R., Heckbert, S. R., Li, L., Heagerty, P. J., Marsh, T. L., & Nelson, J. C. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2320 · Cited by 48
A group sequential Holm procedure with multiple primary endpoints
Ye, Y., Li, A., Liu, L., & Yao, B. (2012) · Statistics in Medicine · doi:10.1002/sim.5700 · Cited by 48
Exact Confidence Bounds Following Adaptive Group Sequential Tests
Brannath, W., Mehta, C. R., & Posch, M. (2008) · Biometrics · doi:10.1111/j.1541-0420.2008.01101.x · Cited by 48
Activity of trabectedin in germline BRCA1/2-mutated metastatic breast cancer: results of an international first-in-class phase II study
Delaloge, S., Wolp-Diniz, R., Byrski, T., Blum, J. L., Gonçalvès, A., Campone, M., Lardelli, P., Kahatt, C. M., Nieto, A., Cullell-Young, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu134 · Cited by 48
Transfusion requirements in septic shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU: protocol for a randomised controlled trial
Holst, L. B., Haase, N., Wetterslev, J., Wernerman, J., Åneman, A., Guttormsen, A. B., Johansson, P. I., Karlsson, S., Klemenzson, G., Winding, R., et al. (2013) · Trials · doi:10.1186/1745-6215-14-150 · Cited by 48
Treatment Comparisons Based on Two‐Dimensional Safety and Efficacy Alternatives in Oncology Trials
Thall, P. F., & Chengt, S. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00746.x · Cited by 48
Data and Safety Monitoring Boards
Friedman, L. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012274065-7/50008-3 · Cited by 48
Upper bounds for type I and type II error rates in conditional power calculations
Davis, B. R., & Hardy, R. J. (1990) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929008830398 · Cited by 48
Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial—Protocol and statistical analysis plan
Meyhoff, T. S., Hjortrup, P. B., Møller, M. H., Wetterslev, J., Lange, T., Kjær, M. N., Jonsson, A. B., Hjortsø, C. J. S., Cronhjort, M., Laake, J. H., et al. (2019) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13434 · Cited by 47
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
Martí-Carvajal, A. J., Anand, V., & Solà, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010298.pub2 · Cited by 46
Contributions of authors
Ender, S. A., Machner, A., Pap, G., Hubbe, J., Graßhoff, H., & Hw, N. (2007) · Acta Orthopaedica · doi:10.1080/17453670710014301 · Cited by 48
Modified Directly Observed Antiretroviral Therapy Compared With Self-administered Therapy in Treatment-Naïve HIV-1–Infected Patients
Gross, R. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.172 · Cited by 47
Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team
Noy, A., Scadden, D. T., Lee, J. Y., Dezube, B. J., Aboulafia, D. M., Tulpule, A., Walmsley, S. L., & Gill, P. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.043 · Cited by 47
The design of the mortality assessment in congestive heart failure trial (MACH‐1, Mibefradil)
Levine, T. B. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200404 · Cited by 47
On Stopping a Randomized Clinical Trial for Futility
Herson, J., Buyse, M. E., & Wittes, J. T. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0140-7_5 · Cited by 46
Essential statistical principles of clinical trials of pain treatments
Dworkin, R. H., Evans, S. R., Mbowe, O. B., & McDermott, M. (2020) · PAIN Reports · doi:10.1097/pr9.0000000000000863 · Cited by 52
Randomized clinical trials comparing antibiotic therapy with appendicectomy for uncomplicated acute appendicitis: meta-analysis
Herrod, P., Kwok, A. T., & Lobo, D. N. (2022) · BJS Open · doi:10.1093/bjsopen/zrac100 · Cited by 46
Randomized Phase IIIb Trial Evaluating the Continuation of Bevacizumab Beyond Disease Progression in Patients with Advanced Non-Squamous Non–Small-Cell Lung Cancer after First-Line Treatment with Bevacizumab Plus Platinum-Based Chemotherapy: Treatment Rationale and Protocol Dynamics of the AvaALL (MO22097) Trial
Gridelli, C., Bennouna, J., de Castro, J., Dingemans, A. C., Griesinger, F., Grossi, F., Rossi, A., Thatcher, N., Wong, E. K., & Langer, C. J. (2011) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.05.002 · Cited by 46
A group sequential t-test with updating of sample size
Denne, J. S. (2000) · Biometrika · doi:10.1093/biomet/87.1.125 · Cited by 46
Laser Treatment in Patients with Bilateral Large Drusen: The Complications of Age-Related Macular Degeneration Prevention Trial
VANDER, J. F. (2007) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)70105-9 · Cited by 46
Issues in the design of multisite clinical trials of psychotherapy: VA Cooperative Study No. 494 as an example
Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Resick, P. A., James, K. E., & Chow, B. K. (2005) · Contemporary Clinical Trials · doi:10.1016/j.cct.2005.09.001 · Cited by 46
Clinical Trial Data and Safety Monitoring Boards
Armstrong, P. W., & Furberg, C. D. (1995) · Circulation · doi:10.1161/01.cir.91.3.901 · Cited by 46
Group Sequential Distribution-Free Methods for the Analysis of Multivariate Observations
Su, J. Q., & Lachin, J. M. (1992) · Biometrics · doi:10.2307/2532696 · Cited by 46
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
Moritani, K., Kanemitsu, Y., Shida, D., Shitara, K., Mizusawa, J., Katayama, H. G., Hamaguchi, T., & Shimada, Y. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz173 · Cited by 45
Classification and effectiveness of different oxygenation goals in mechanically ventilated critically ill patients: network meta-analysis of randomised controlled trials
Zhao, X., Xiao, H., Dai, F., Brodie, D., & Meng, L. (2021) · European Respiratory Journal · doi:10.1183/13993003.02928-2020 · Cited by 45
Repeated confidence intervals for adaptive group sequential trials
Mehta, C. R., Bauer, P., Posch, M., & Brannath, W. (2007) · Statistics in Medicine · doi:10.1002/sim.3062 · Cited by 45
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial
Alshahrani, M. S. S., Alsulaibikh, A. H., Tahan, M. R. E., Alfaraj, S. Z., Asonto, L. P., Almulhim, A., AlAbbad, M. F., Maghraby, N., Aljumaan, M. A., Aljunaid, T. O., et al. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14382 · Cited by 45
Adaptive, group sequential and decision theoretic approaches to sample size determination
Mehta, C. R., & Patel, N. R. (2006) · Statistics in Medicine · doi:10.1002/sim.2638 · Cited by 45
Group sequential, sample size re‐estimation and two‐stage adaptive designs in clinical trials: a comparison
Shih, W. J. (2005) · Statistics in Medicine · doi:10.1002/sim.2252 · Cited by 45
Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial
Palomba, S., Falbo, A. I., Cello, A. D., Cappiello, F., Tolino, A., & Zullo, F. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.020 · Cited by 45
Application of bayesian statistics to decision making during a clinical trial
Freedman, L. S., & Spiegelhalter, D. J. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110105 · Cited by 45
A randomized double-blind trial to compare the clinical efficacyof granisetron with metoclopramide, both combined with dexamethasone in the prophylaxis of chemotherapy-induced delayed emesis
Aapro, M., Thuerlimann, B., Sessa, C., de Pree, C., Bernhard, J., & Maibach, R. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg075 · Cited by 45
Power-Enhanced Multiple Decision Functions Controlling Family-Wise Error and False Discovery RatesPreprint
Peña, E. A., Habiger, J., & Wu, W. (2009) · Cited by 45
Exact inference for adaptive group sequential designs
Gao, P., Liu, L., & Mehta, C. R. (2013) · Statistics in Medicine · doi:10.1002/sim.5847 · Cited by 44
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation
Lewis, R. J., Lipsky, A. M., & Berry, D. A. (2007) · Clinical Trials · doi:10.1177/1740774506075764 · Cited by 44
Point Estimation Following Group Sequential Tests
Kim, K. (1989) · Biometrics · doi:10.2307/2531502 · Cited by 44
Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure
Packer, M., Pitt, B., Rouleau, J. L., Swedberg, K. B., DeMets, D. L., & Fisher, L. D. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.03.003 · Cited by 45
Self-citation
The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial
Findling, R. L., Pagano, M. E., McNamara, N., Stansbrey, R. J., Faber, J. E., Lingler, J., Demeter, C., Bedoya, D., & Reed, M. D. (2009) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-3-11 · Cited by 44
The ESCAPE Investigators and ESCAPE Study Coordinators* ESCAPE Trial Pulmonary Artery Catheterization Effectiveness: The Evaluation Study of Congestive Heart Failure and
Hall, J. B. (2009) · Cited by 45
A Practical Comparison of Group-Sequential and Adaptive Designs
Kelly, P. J., Sooriyarachchi, M. R., Stallard, N., & Todd, S. (2005) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-200062859 · Cited by 44
Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)
Afshari, A., Brok, J. S., Møller, A. M., & Wetterslev, J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007733.pub2 · Cited by 44
A Brief Review on Software Developments for Group Sequential and Adaptive Designs
Wassmer, G., & Vandemeulebroecke, M. (2006) · Biometrical Journal · doi:10.1002/bimj.200510233 · Cited by 43
Monitoring multi‐armed trials
Proschan, M. A., Follmann, D. A., & Geller, N. L. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131320 · Cited by 43
Sample Size Reestimation in Clinical Trials
Shun, Z. (2001) · Drug Information Journal · doi:10.1177/009286150103500437 · Cited by 43
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol
Makuuchi, R., Terashima, M., Terada, M., Mizusawa, J., Kita, R., Tokunaga, M., Omori, T., Ojima, T., Ehara, K., Watanabe, M., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11481-2 · Cited by 42
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review
Hamasaki, T., Evans, S. R., & Asakura, K. (2017) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543406.2017.1378668 · Cited by 43
Short-term Preoperative Diet Decreases Bleeding After Partial Hepatectomy
Barth, R. J., Mills, J. B., Suriawinata, A. A., Putra, J., Tosteson, T. D., Axelrod, D. A., Freeman, R. B., Whalen, G. F., LaFemina, J., Tarczewski, S. M., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002709 · Cited by 42
Pressure Relieving Support Surfaces for Pressure Ulcer Prevention (PRESSURE 2): Clinical and Health Economic Results of a Randomised Controlled Trial
Nixon, J., Smith, I. L., Brown, S. T., McGinnis, E., Vargas‐Palacios, A., Nelson, E. A., Coleman, S. B., Collier, H., Fernandez, C., Gilberts, R. M., et al. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.07.018 · Cited by 42
Stopping guidelines for clinical trials with multiple treatments
Hughes, M. D. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121002 · Cited by 42
Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL)
Betticher, D. C., Martinelli, G., Radford, J. A., Kaufmann, M., Dyer, M. J. S., Kaiser, U., Aulitzky, W. E., Beck, J. T., von Rohr, A., Kovascovics, T. J., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl153 · Cited by 42
Sequential monitoring of response-adaptive randomized clinical trials
Zhu, H., & Hu, F. (2010) · The Annals of Statistics · doi:10.1214/10-aos796 · Cited by 42
Early methodological developments for clinical trials at the national heart, lung and blood institute
Halperin, M., DeMets, D. L., & Ware, J. H. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090804 · Cited by 42
Self-citation
Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.
Fetting, J. H., Gray, R. J., Fairclough, D. L., Smith, T. J., Margolin, K. A., Citron, M. L., Grove-Conrad, M., Cella, D. F., Pandya, K. J., Robert, N. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2382 · Cited by 42
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study
de la Fouchardière, C., Malka, D., Cropet, C., Chabaud, S., Raimbourg, J., Botsen, D., Launay, S., Evesque, L., Vienot, A., Perrier, H., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.00795 · Cited by 43
Synthesizing medical evidence: systematic reviews and metaanalyses
Barker, F. G., & Carter, B. S. (2005) · Neurosurgical FOCUS · doi:10.3171/foc.2005.19.4.6 · Cited by 41
Sample Size Re-estimation Designs In Confirmatory Clinical Trials—Current State, Statistical Considerations, and Practical Guidance
Pritchett, Y., Menon, S., Marchenko, O., Antonijevic, Z., Miller, E. R., Sanchez‐Kam, M., Morgan-Bouniol, C. C., Nguyen, H., & Prucka, W. R. (2015) · Statistics in Biopharmaceutical Research · doi:10.1080/19466315.2015.1098564 · Cited by 41
Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
Madsen, K. S., Kähler, P., Kähler, L. K. A., Madsbad, S., Gnesin, F., Metzendorf, M., Richter, B., & Hemmingsen, B. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012368.pub2 · Cited by 43
Goodness-of-fit statistics for age-specific reference intervals
Royston, P. J., & Wright, E. M. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001115)19:21 · Cited by 208
An overview of sequential methods and their application in clinical trials
DeMets, D. L., & Lan, G. (1984) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928408828829 · Cited by 41
Self-citation
A conditional sequential sampling procedure for drug safety surveillance
Li, L. (2009) · Statistics in Medicine · doi:10.1002/sim.3689 · Cited by 40

Authors: GORDON LAN, K. K., & DEMETS, D. L.
Affiliations: University of Wisconsin–Madison (US)
Venue: Biometrika
Publisher: Oxford University Press (OUP)
Published: 1983
Volume: 70
Issue: 3
Pages: 659-663
ISSN: 0006-3444 (ISSN-L)
1464-3510
DOI: 10.1093/biomet/70.3.659
OpenAlex: W1990639292
Cited by: 2,310
References: 10
Citations by year: 2026: 51 · 2025: 69 · 2024: 80 · 2023: 78 · 2022: 63 · 2021: 73 · 2020: 77 · 2019: 96 · 2018: 76 · 2017: 89 · 2016: 90 · 2015: 72 · 2014: 112 · 2013: 73 · 2012: 101
FWCI: 7.06
Type: journal article
Language: en
Open access: closed
Locations: Biometrika (publishedVersion)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Probability and Statistical Research
Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Keywords: clinical trials, early stopping, alpha spending functions, sequential analysis, decision time, error rate control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Discrete sequential boundaries for clinical trials

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks